Alain Beck

Alain Beck

Centre d'Immunologie Pierre Fabre
Verified email at pierre-fabre.com
Cited by 17931
Therapeutic Antibodies
Phillip W Berman

Phillip W Berman

University of California Santa Cruz
Verified email at soe.ucsc.edu
Cited by 15726
vaccines therapeutic antibodies glycosylation CHO cell engineering
Jon H Condra

Jon H Condra

independent consultant
Cited by 11341
cancer immunotherapy virology drug discovery HIV therapeutic antibodies
David Lee

David Lee

Abbvie Inc.
Verified email at abbott.com
Cited by 10172
antibody drug conjugates therapeutic antibodies biosimilars SITRS SILAC
Pavlo Gilchuk

Pavlo Gilchuk

AstraZeneca
Verified email at astrazeneca.com
Cited by 7863
Viruses therapeutic antibodies antibody discovery platforms
Björn Frendéus

Björn Frendéus

Chief Scientific Officer, BioInvent
Verified email at bioinvent.com
Cited by 4061
Therapeutic Antibodies
Anja Lux

Anja Lux

Friedrich-Alexander-Universität Erlangen-Nürnberg
Verified email at fau.de
Cited by 3552
IgG glycosylation FcRs autoimmunity therapeutic antibodies
Thomas SECHER

Thomas SECHER

Research Scientist (CRCN, INSERM), Tours, France
Verified email at univ-tours.fr
Cited by 3369
Therapeutic antibodies Inflammation Innate immunity Immunopathology Animal models of human pathology
Olav Olsen

Olav Olsen

Regeneron Pharmaceuticals
Verified email at regeneron.com
Cited by 2837
Neuroscience Therapeutic antibodies
Luke Robinson

Luke Robinson

Sr. Director of Research, Visterra Inc
Verified email at visterrainc.com
Cited by 1757
therapeutic antibodies antibody engineering ion channels scRNA-seq
1 - 10